Literature DB >> 23223155

Generation of integration-free neural progenitor cells from cells in human urine.

Lihui Wang1, Linli Wang, Wenhao Huang, Huanxing Su, Yanting Xue, Zhenghui Su, Baojian Liao, Haitao Wang, Xichen Bao, Dajiang Qin, Jufang He, Wutian Wu, Kwok Fai So, Guangjin Pan, Duanqing Pei.   

Abstract

Human neural stem cells hold great promise for research and therapy in neural disease. We describe the generation of integration-free and expandable human neural progenitor cells (NPCs). We combined an episomal system to deliver reprogramming factors with a chemically defined culture medium to reprogram epithelial-like cells from human urine into NPCs (hUiNPCs). These transgene-free hUiNPCs can self-renew and can differentiate into multiple functional neuronal subtypes and glial cells in vitro. Although functional in vivo analysis is still needed, we report that the cells survive and differentiate upon transplant into newborn rat brain.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23223155     DOI: 10.1038/nmeth.2283

Source DB:  PubMed          Journal:  Nat Methods        ISSN: 1548-7091            Impact factor:   28.547


  42 in total

1.  Feeder-independent culture of human embryonic stem cells.

Authors:  Tenneille E Ludwig; Veit Bergendahl; Mark E Levenstein; Junying Yu; Mitchell D Probasco; James A Thomson
Journal:  Nat Methods       Date:  2006-08       Impact factor: 28.547

2.  Generation of isogenic pluripotent stem cells differing exclusively at two early onset Parkinson point mutations.

Authors:  Frank Soldner; Josée Laganière; Albert W Cheng; Dirk Hockemeyer; Qing Gao; Raaji Alagappan; Vikram Khurana; Lawrence I Golbe; Richard H Myers; Susan Lindquist; Lei Zhang; Dmitry Guschin; Lauren K Fong; B Joseph Vu; Xiangdong Meng; Fyodor D Urnov; Edward J Rebar; Philip D Gregory; H Steve Zhang; Rudolf Jaenisch
Journal:  Cell       Date:  2011-07-14       Impact factor: 41.582

3.  Neural stem cells: historical perspective and future prospects.

Authors:  Joshua J Breunig; Tarik F Haydar; Pasko Rakic
Journal:  Neuron       Date:  2011-05-26       Impact factor: 17.173

4.  Direct reprogramming of mouse fibroblasts to neural progenitors.

Authors:  Janghwan Kim; Jem A Efe; Saiyong Zhu; Maria Talantova; Xu Yuan; Shufen Wang; Stuart A Lipton; Kang Zhang; Sheng Ding
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-26       Impact factor: 11.205

5.  Direct reprogramming of fibroblasts into neural stem cells by defined factors.

Authors:  Dong Wook Han; Natalia Tapia; Andreas Hermann; Kathrin Hemmer; Susanne Höing; Marcos J Araúzo-Bravo; Holm Zaehres; Guangming Wu; Stefan Frank; Sören Moritz; Boris Greber; Ji Hun Yang; Hoon Taek Lee; Jens C Schwamborn; Alexander Storch; Hans R Schöler
Journal:  Cell Stem Cell       Date:  2012-03-22       Impact factor: 24.633

6.  Suppression of SHP-2 and ERK signalling promotes self-renewal of mouse embryonic stem cells.

Authors:  T Burdon; C Stracey; I Chambers; J Nichols; A Smith
Journal:  Dev Biol       Date:  1999-06-01       Impact factor: 3.582

7.  Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.

Authors:  Kazutoshi Takahashi; Shinya Yamanaka
Journal:  Cell       Date:  2006-08-10       Impact factor: 41.582

8.  Periodic activation of Wnt/beta-catenin signaling enhances somatic cell reprogramming mediated by cell fusion.

Authors:  Frederic Lluis; Elisa Pedone; Stefano Pepe; Maria Pia Cosma
Journal:  Cell Stem Cell       Date:  2008-11-06       Impact factor: 24.633

9.  In vivo reprogramming of adult pancreatic exocrine cells to beta-cells.

Authors:  Qiao Zhou; Juliana Brown; Andrew Kanarek; Jayaraj Rajagopal; Douglas A Melton
Journal:  Nature       Date:  2008-08-27       Impact factor: 49.962

10.  Probing sporadic and familial Alzheimer's disease using induced pluripotent stem cells.

Authors:  Mason A Israel; Shauna H Yuan; Cedric Bardy; Sol M Reyna; Yangling Mu; Cheryl Herrera; Michael P Hefferan; Sebastiaan Van Gorp; Kristopher L Nazor; Francesca S Boscolo; Christian T Carson; Louise C Laurent; Martin Marsala; Fred H Gage; Anne M Remes; Edward H Koo; Lawrence S B Goldstein
Journal:  Nature       Date:  2012-01-25       Impact factor: 49.962

View more
  77 in total

Review 1.  Direct lineage conversion of astrocytes to induced neural stem cells or neurons.

Authors:  Yanhua Huang; Sheng Tan
Journal:  Neurosci Bull       Date:  2015-04-08       Impact factor: 5.203

Review 2.  Understanding Parkinson's Disease through the Use of Cell Reprogramming.

Authors:  Rebecca Playne; Bronwen Connor
Journal:  Stem Cell Rev Rep       Date:  2017-04       Impact factor: 5.739

Review 3.  Using Patient-Derived Induced Pluripotent Stem Cells to Model and Treat Epilepsies.

Authors:  Xixi Du; Jack M Parent
Journal:  Curr Neurol Neurosci Rep       Date:  2015-10       Impact factor: 5.081

4.  Direct conversion of human fibroblasts into neuronal restricted progenitors.

Authors:  Qingjian Zou; Quanmei Yan; Juan Zhong; Kepin Wang; Haitao Sun; Xiaoling Yi; Liangxue Lai
Journal:  J Biol Chem       Date:  2014-01-02       Impact factor: 5.157

Review 5.  Roles of small molecules in somatic cell reprogramming.

Authors:  Jian-bin Su; Duan-qing Pei; Bao-ming Qin
Journal:  Acta Pharmacol Sin       Date:  2013-06-03       Impact factor: 6.150

Review 6.  Will brain cells derived from induced pluripotent stem cells or directly converted from somatic cells (iNs) be useful for schizophrenia research?

Authors:  Cheryl Filippich; Ernst J Wolvetang; Bryan J Mowry
Journal:  Schizophr Bull       Date:  2013-07-24       Impact factor: 9.306

7.  Small molecules enable OCT4-mediated direct reprogramming into expandable human neural stem cells.

Authors:  Saiyong Zhu; Rajesh Ambasudhan; Woong Sun; Hyun Jung Kim; Maria Talantova; Xiaojing Wang; Mingliang Zhang; Yu Zhang; Timothy Laurent; James Parker; Han-Seop Kim; Jeffrey D Zaremba; Sofiyan Saleem; Sara Sanz-Blasco; Eliezer Masliah; Scott R McKercher; Yee Sook Cho; Stuart A Lipton; Janghwan Kim; Sheng Ding
Journal:  Cell Res       Date:  2013-12-03       Impact factor: 25.617

8.  Reprogramming fibroblasts toward cardiomyocytes, neural stem cells and hepatocytes by cell activation and signaling-directed lineage conversion.

Authors:  Saiyong Zhu; Haixia Wang; Sheng Ding
Journal:  Nat Protoc       Date:  2015-06-04       Impact factor: 13.491

Review 9.  Small molecules for reprogramming and transdifferentiation.

Authors:  Hua Qin; Andong Zhao; Xiaobing Fu
Journal:  Cell Mol Life Sci       Date:  2017-07-11       Impact factor: 9.261

Review 10.  Cell Therapy for Parkinson's Disease: New Hope from Reprogramming Technologies.

Authors:  Zhiguo Chen
Journal:  Aging Dis       Date:  2015-11-17       Impact factor: 6.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.